Whole-body PET: Physiological and artifactual fluorodeoxyglucose accumulations

Journal of Nuclear Medicine

Volumn 37, Issue 3, 1996, Pages 441-446

  Engel, Hermann ^a   Steinert, Hans ^a   Buck, Alfred ^a   Berthold, Thomas ^a   Huch Böni, Rahel A ^a   Von Schulthess, Gustav K ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

fluorine 18 FDG; PET; physiological accumulations

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; ARTIFACT; CLINICAL ARTICLE; FEMALE; GLUCOSE INTAKE; HUMAN; IMAGE ANALYSIS; MALE; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOFT TISSUE; WHOLE BODY SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; ARTIFACTS; DEOXYGLUCOSE; EXERCISE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTESTINES; MALE; MELANOMA; MIDDLE AGED; MUSCLE, SKELETAL; NEOPLASM STAGING; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029991060     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Som P, Atkins HL, Bandoypadhyay D, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18) nontoxic tracer for rapid tumor detection. J Nucl Med 1980,21:670-673.
2. Strauss LG, Conti PS The applications of PET in clinical oncology. J Nucl Med 1991;32:623-648.
3. Hawkins RA, Hoh CK, Glaspy JA, et al. The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med 1992,22:268-284.
4. 18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 1993;17:582-589
5. Jabour B, Choi Y, Hoh CK, et al. Extracranial head and neck PET imaging with 2-[F-18] fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993;186. 27-35.
6. Wahl RL, Helvie MA, Chang AE, Andersson I. Detection of breast cancer in women after augmentation mammoplasty using fluorine-18-fluorodeoxyglucose-PET. J Nucl Med 1994;35:872-875
7. 18F]-fluoro-2-deoxy-D-glucose, correlation with CT. Radiology 1994;190: 111-116.
8. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images, preliminary prospective evaluation Radiology 1994;191:371-377.
9. Tyler J, Strother S, Zatorre R, et al Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography. J Nucl Med 1988;29:631-642.
10. 18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects. Eur J Nucl Med 1990,16:267-273.
11. Schwaiger M, Hicks R The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991;32.565-578.
12. 18F]-fluoro-2-deoxy-D glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 1993,20.308-318.
13. Voipio-Pulkki LM, Nuutila P, Knuuti MJ, et al. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med 1993;34 2064-2067.
14. 18F]-fluoro-2-deoxy-D glucose using amionpolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-238.
15. Dahlbom M, Hoffman EJ, Hoh CK, et al. Whole-body positron emission tomography: Part I Methods and performance characteristics J Nucl Med 1992;33:1191-1199
16. Oda K, Senda M, Toyama H, Ishii K, Amano M Attenuation correction using postinjection transmission measurements for PET: the optimization of measurement conditions. Kaku Igaku 1994,31:37-41